Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5396826ac8c36d31e3eb53c9ef088a68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_615a74234927fad1b0d64ed7b95e5d2c |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-76 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-75 |
filingDate |
2017-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86c4defb3ec53c8a64378950646c6fc0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26db3bfe1920976d7e2218d8f999d575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_157787f300c2485b3445f3096889684b |
publicationDate |
2017-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20170085980-A |
titleOfInvention |
Pharmaceutical composition comprising pyridinol derivative or a pharmaceutically acceptable salt |
abstract |
The present invention relates to a pharmaceutical composition for the prevention or treatment of inflammatory bowel disease, which comprises a pyridinol derivative or a pharmaceutically acceptable salt thereof as an active ingredient, wherein the pyridinol derivative represented by the formula (I) or a pharmaceutically acceptable salt thereof has an inflammatory The colitis inhibitory effect in the intestinal disease model is excellent and can be usefully used as a medicine for the prophylaxis or treatment of inflammatory bowel disease. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190116094-A |
priorityDate |
2016-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |